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Case Reports

Woman with Mental Status Change
Vanita Treat MD, PGY-3

An 83 year-old African-American female with a history
of hypertension, frequent urinary tract infections, atrial
fibrillation, and a cerebrovascular accident (CVA) on
Coumadin presented two days after a fall. A family
member stated she was walking normally and tripped on
uneven concrete, hitting her chin on a fence. Two days
after the incident, the patient was found at home
slumped over in a chair with blood oozing from her chin
wound. The patient was brought to the emergency
department where she was lethargic but responsive. The
patient denied any chest pain, shortness of breath,
lightheadedness, dizziness, blurry vision, weakness or
incontinence. Her speech was slightly slurred. The
patient also denied nausea, vomiting, headache or fevers.
She did report some pain over her jaw. There was no
other significant past medical, surgical, or family history.
Her home medications included 3mg of Coumadin and
12.5mg of Toprol daily. She had no known drug allergies.
On physical exam, the patient was found to have a fever
of 102.7 F, a heart rate of 68 beats per minute, a blood
pressure of 115/67 mm Hg, a respiratory rate of 16
breaths per minute and an oxygen saturation of 99% on
2 liters of oxygen. Her blood sugar was 26 mg/dL on
admission and she was given intravenous (IV) dextrose.
She was lethargic but arousable and responded to both
verbal and tactile stimuli. Orientation was difficult to
assess, but the patient was not at her baseline as per her
family. Her extraocular movements were intact and her
pupils were equal round and reactive to light. She had
an area of ecchymosis and an abrasion over her chin. Her
heart rate was irregularly irregular. There were no
murmurs, rubs or gallops. Her lung exam was clear
bilaterally. Her abdomen was soft, nontender and
nondistended. She had normal active bowel sounds and
was heme negative rectally. She had no edema in her
extremities. Her neurological exam was difficult to assess
secondary to lack of cooperation. She did have
spontaneous movements in all four extremities.
Laboratory data on admission showed a white blood cell
count of 4k/L (4 -11), a hemoglobin of 12.4 g/dL (12.515), and a platelet count of 146k/L (140-400). She had
a sodium of 135 mmol/L (135-146), potassium of 4.9
mmol/L (3.5-5.0), chloride of 100 mmol/L (98-109),
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bicarbonate of 28 mmol/L (24-32), BUN of 8 mg/dL
(12-27), creatinine of 0.9 mg/dL (0.7-1.4), and a glucose
of 56 mg/dL (60-110). Her calcium was normal. Her
PTT was 30 sec (22-36), her PT was 24.2 sec (13.4-15.8)
and her INR was therapeutic at 2.03. In the emergency
room, she had a head CT which showed no focal
abnormalities and no signs of hemorrhage. Her urine
drug screen was negative and a urinalysis showed no
evidence of infection. Her troponins were negative times
three. Blood and urine cultures were sent. She had a CXR
which showed no active disease. An EKG on admission
showed atrial fibrillation at a rate of 93 beats per minute.
A TSH was 0.91 uIU/ml (0.4-4.8). B12 and folate levels
were normal as well.
The patient started to become more confused and so a
lumbar puncture was performed. The CSF findings were
unremarkable. The patient defervesced and all cultures
were normal. Neurology recommended an EEG which
was consistent with multi-infarct dementia and
metabolic encephalopathy. An MRI of the brain showed
no acute infarcts or hemorrhage. There was evidence of
old ischemia and a slightly enlarged pituitary gland.
Her sodium had dropped significantly during her
hospital stay to a low of 119 mmol/L and her blood
pressure dropped to a systolic range of 80-90mmHg. At
that time, a cortisol level was checked and was found to
be 1.3 mcg/dL. A repeat TSH was 0.68 uIU/mL. She
had a free T4 of 0.5 ng/dL and a total T3 of 69 ng/dL,
both of which were low. An endocrine consult was
obtained and a dedicated pituitary MRI was
recommended as well as IV steroids (hydrocortisone
100gms IV every 8 hours was used). The patient was also
started on 25mcg of Synthroid daily. Her hyponatremia
improved dramatically as did her mental status. An
ACTH level was low at 8 pg/mL (9-52) and a
somatomedin-C level was low at 19 ng/mL (71-290). A
prolactin level was normal at 19 ng/mL (0-19) and an
IGF-1 was ordered but not completed. The dedicated
pituitary MRI showed diffuse hemorrhage involving the
pituitary gland with a probable underlying
macroadenoma. It was presumed that the patient had
pituitary apoplexy.
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Discussion
Pituitary apoplexy is a rare but serious condition caused
by sudden hemorrhage or infarction of the pituitary
gland. Typically, there is an underlying pituitary
adenoma. A classic presentation is characterized by
sudden headache, vomiting, visual impairment and
meningismus. Headache is usually the most common
presenting symptom. Some precipitating factors of
pituitary apoplexy include anticoagulation and head
trauma, both of which were present in this case. Other
precipitating factors include hypertension, radiation
therapy, recent surgery, bromocriptine therapy and
dynamic pituitary function testing. The clinical
presentation can vary greatly ranging from a mild
headache to hemodynamic compromise. If blood enters
the subarachnoid space, meningitis-like symptoms
including fever, meningismus, vomiting and altered
mental status can occur. These patients deteriorate very
rapidly. The urgency of surgical decompression depends
on the presentation, and many of these cases are managed
conservatively.
The key to diagnosis is to first recognize the condition.
Initial laboratory data should include a complete blood
count, coagulation studies, electrolytes, a baseline
cortisol level and thyroid function tests. Pituitary
hormone deficiency is very common. Hypogonadism,
growth hormone deficiency, and prolactin abnormalities
occur in many cases. Acute adrenal insufficiency (AI) can
be very serious and is found in 2/3 of cases.
Hypothyroidism is found in about 42% of cases.
Diabetes insipidus can occur from damage to the

posterior pituitary gland and is seen in only about 4% of
cases. Electrolyte disturbances, especially hyponatremia,
are also common. Hyponatremia can occur from
inappropriate ADH secretion, secondary AI, or
secondary hypothyroidism. Laboratory data to check for
hypopituitarism include TSH, prolactin, LH, FSH,
cortisol, GH, estradiol in females and testosterone in
males. A lumbar puncture can be performed to rule out
meningitis and subarachnoid bleed. Radiologic studies
are used to confirm the presence of pituitary apoplexy.
Imaging by CT is often used acutely, however MRI is
preferred because it is more sensitive and is often used in
the subacute setting. Management involves supportive
care, “stress-dose” steroids, and a neurosurgical
evaluation. Hydrocortisone 100mg IV every 6-8 hours is
often used or dexamethasone 4mg IV every 8 hours or
equivalent. Pituitary hormone replacement is used when
necessary. Transsphenoidal surgery may be indicated if
there are visual changes. Radiotherapy is not indicated
immediately since the risk of recurrence is negligible.
Careful follow-up is recommended.
References
1. Biousse V, Newman NJ, Oyesiku NM. Precipitating
factors in pituitary apoplexy. J Neurol Neurosurg
Psychiatry 2001;71:542-545.
2. Goldberg PA, Inzucchi SE. Critical issues in
endocrinology. Clinics in Chest Medicine 2003;24(4):
583-606.
3. Levy A. Pituitary disease: presentation, diagnosis, and
management. Neurology in Practice 2004;75:iii47-iii52.
4. Randeva HS, et al. Classical pituitary apoplexy. Clinical
Endocrinology 1999;51(2):181-8.
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Case Reports

Woman With Post-Partum Kidney and Liver Failure
Joshua Gibbs MD, PGY-3

The patient is a 34 year-old G1P1 Caucasian female with
no medical history who was transferred from an outside
hospital after an emergent Cesarean section for increasing
jaundice with elevated liver enzymes, abnormal
coagulation times and acute renal failure. The patient
was healthy until 33 weeks gestation when she noted
dizziness, headache and visual changes. Blood pressure at
that time was elevated at 140/90 and she had trace lower
extremity edema. No proteinuria was detected. The
clinical picture was consistent with mild pre-eclampsia.
The patient was followed until 35 weeks gestation when
she developed vaginal bleeding and abdominal pain. At
that time, an emergency C-section was performed due
to a non-reassuring fetal heart rate. On the first night
after the surgery, she became anuric and laboratory tests
demonstrated acute renal failure, coagulopathy, and
elevated liver enzymes. She became progressively
jaundiced and she was transferred for further
management. On admission, she complained of nausea
and malaise. She denied abdominal pain, chest pain,
dyspnea, lightheadedness or headache.
Her past medical history was only significant for
endometriosis. Her past surgical history included
laparoscopic treatment of endometriosis several years ago
and ovarian cyst removal several years ago. Her
medications included Phenergan, Percocet, Lasix and
Dulcolax. She had allergies to Augmentin and Ceclor
which caused a rash. Her family history was noncontributory. The patient noted occasional tobacco use,
denied alcohol or other substances. Her review of systems
was only significant for mild dyspnea, nausea, mild
gingival bleeding, and mild pruritis.
Vital signs showed a temperature of 99.0F, pulse of 84
beats per minute, respirations of 22 breaths per minute,
blood pressure of 130/70 with blood oxygenation at 99%
on room air. Her physical examination was significant for
scleral icterus; her heart rate was regular without murmurs,
rubs or gallops; her lungs had bibasilar crackles; her
abdomen was soft with some tenderness at her incision
site with minimal oozing; she had moderate lochia and
was heme negative rectally; she had 2+ pitting edema on
her bilateral lower extremities; neurologic examination was
intact with some asterixis noted.
Her laboratory findings on admission were significant for
a sodium of 122mg/dL, potassium of 5.2mmol/L,
bicarbonate of 17mmol/L, BUN of 33mg/dL, creatinine
3

of 3.3 mg/dL, PTT of 55.6 sec, PT of 23 sec, INR of 2.5,
fibrinogen of 94mg/dL, protein of 3.9g/dL, albumin of
2.0g/dL, total bilirubin of 9.7mg/dL, direct bilirubin of
5.4mg/dL, AST of 124mg/dL, ALT of 104mg/dL, alkaline
phosphatate of 390U/L, ammonia of 57mol/L, white
blood cell count of 15.6k/L, hemoglobin of 9.6g/dL,
platelets of 174k/L, and a urinalysis with 3+ protein.
Her chest X-ray showed mild pulmonary vascular
congestion. A right upper quadrant ultrasound showed
decreased flow in hepatic vein and mild ascites. Her
MRI/MRA/MRV of the abdomen showed narrowing of
hepatic vein and inferior vena cava (IVC). The renal
ultrasound showed no hydronephrosis.
Discussion
This case allows the discussion of liver disease during
pregnancy, however the focus of this discussion will be
on the Budd-Chiari Syndrome (BCS).
Pathogenesis
The patient in this case had signs and symptoms
consistent with BCS or hepatic venous outflow
obstruction. BCS describes a group of disorders that cause
outflow obstruction at the level of the hepatic venule,
large hepatic veins, inferior vena cava or right atrium.
Hepatic veno-occlusive disease refers to obstruction at the
level of the center of sub-lobular hepatic veins. Hepatic
venous outflow tract obstruction results in increased
sinusoidal pressure and portal hypertension. Early in the
disease, portal venous perfusion is diminished which may
result in portal vein thrombosis. Venous stasis leads to
centrolobular necrosis, fibrosis and eventually cirrhosis. If
a portosystemic shunt is created or portal venous
collaterals develop, liver function improves by reducing
sinusoidal pressure. About 75% of patients have an
identifiable cause of BCS. Hereditary and acquired
hypercoagulable states are a common cause.
Myeloproliferative disorders are the most common cause
of BCS, most notably polycythemia vera. Other causes
include paroxysmal nocturnal hemoglobinuria, antiphospholipid syndrome, inherited deficiencies of proteins C
and S and antithrombin III. BCS has been described in
pregnancy and the immediate post-partum period.
Clinical Manifestations
BCS can be grouped into fulminant, acute, subacute and
chronic depending on the speed which the hepatic veins
become occluded and whether collateral circulation
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exists. Abdominal pain, hepatomegaly and ascites are the
most common findings. Nausea, vomiting and jaundice
are more common in the fulminant and acute forms.
Splenomegaly and esophageal varices are more common
in the chronic forms. IVC occlusion usually causes
dilated venous collaterals on the back and flanks. Patients
with acute BCS have ascites, hepatic necrosis, symptoms
of short duration and lack of venous collaterals. Hepatic
necrosis and ascites are usually minimal in the subacute
form because venous collaterals have decompressed the
hepatic sinusoids. The subacute form is the most
common form of BCS. A careful cardiovascular
examination can separate BCS from cardiac causes of
diminished hepatic venous outflow. Right atrial myxoma,
tricuspid regurgitation and constrictive pericarditis can
cause similar symptoms to BCS. Lack of hepatojugular
reflux is indicative of BCS on physical examination.
Diagnosis
Laboratory evaluation shows AST and ALT to be five
times the upper limit of normal in fulminant and acute
forms of BCS. The subacute form has lower values.
Alkaline phosphatase and bilirubin levels are also
elevated. Serum-ascitic fluid albumin gradient is high.
Doppler ultrasound is the diagnostic imaging of choice
with a sensitivity and specificity of 85%. MRI can show
hepatic vein thrombosis and may be better for
delineating acute from subacute and chronic forms.
Hepatic venography is used as a confirmatory test when
ultrasound is negative but there is a strong clinical
suspicion. The classic “spiderweb” pattern is often seen.
The patient in this case had an MRI which showed
narrowing of the hepatic vein and IVC which is
consistent with BCS.
Management
Medical management focuses on treating the underlying
cause, anticoagulation to prevent extension of
thrombosis and efforts to reduce ascites. Diuretics such
as furosemide and spironolactone as well as paracentesis
and sodium restriction are used to reduce ascites.
Heparin is used initially with conversion to warfarin with
a goal INR of 2.0 to 2.5. Medical management is
generally recommended for patients with few symptoms,
no hepatic necrosis and minimal ascites. Patients with
coagulopathy, encephalopathy and hepatorenal
syndrome have a poor prognosis and require immediate
relief of hepatic venous obstruction.

Thrombolytics can be used in the acute form of BCS
particularly when an acute thrombus is seen on
angiography. TPA or urokinase is directly infused by
catheter for 24 hours. The overall success rate is low with
thrombolytics, but positive results have occurred as far
as two to three weeks after onset of symptoms.
Percutaneous or transhepatic angioplasty of segments of
the narrowed hepatic vein can also be performed.
Symptom relief occurs in up to 70% of patients, but
restenosis rates are high.
Transjugular intrahepatic portosystemic shunts (TIPS)
are typically used in patients who have an occluded IVC
when the portal vein-infrahepatic vena caval pressure
gradient is less than 10mm Hg and when there is poor
hepatic reserve. TIPS can also be used in acute BCS after
failure of thrombolytic therapy. TIPS can be used as a
bridge to liver transplantation. Even if the shunt
occludes, it may allow enough time for collaterals to
develop and decrease sinusoidal pressure.
Surgical options include excision of IVC webs followed by
angioplasty of the vena cava, although portosystemic
shunting and liver transplantation are the most common
surgical treatments for BCS. Surgical portosystemic shunts
are recommended in subacute forms of BCS when the
underlying etiology has a favorable outcome, the patient is
a good surgical candidate and when liver biopsy shows
ongoing hepatic necrosis. A portal vein and IVC pressure
gradient of more than 10 mm Hg is associated with a
successful long-term outcome. Examples of surgical shunts
include side-to-side portocaval shunt, central splenorenal
shunt, and a mesocaval shunt. The five-year survival rate
after surgical shunting is between 75% and 94%.
The five-year survival rate for liver transplantation in
patients with BCS is 95%. Indications are an underlying
disease associated with a favorable prognosis, fulminant
hepatic failure, cirrhosis, and failure of portosystemic
shunt. Not all patients require long-term anticoagulant
therapy after liver transplantation, but it may be
reasonable to anticoagulate since patients with BCS have
multiple underlying etiologic factors.
References
1. Menon KV, Shah V, Kamath PS. The Budd-Chiari
Syndrome. N Engl J Med 2004; 350(6): 578-585.
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Woman with a Bleeding Diathesis
Bo Kim MD, PGY-3

61 year-old Indian female with history of hypercholesterolemia presents to an outside hospital (OSH) with
worsening vaginal bleeding, hematochezia, nausea, and
vomiting starting three days prior to admission. Patient
also had a global persistent headache for approximately
24 hours at the time of admission. Otherwise, the patient
denied any fever, chills, abdominal pain, or trauma. The
patient noted no previous episodes of bleeding or easy
bruising in her past. She notes that her menstrual periods
were always regular and not subjectively heavy. Last
menstrual period was 10 years ago. Patient has had two
pregnancies in her obstetric history for which she
delivered vaginally without bleeding complications. The
patient denied recent antibiotic use. She had no change
in diet and no prior transfusions. At the OSH, the
patient was noted to be orthostatic at presentation with
mild tachycardia but was stabilized with intravenous
fluids and transfusions of packed red cells. Patient’s
nausea and vomiting resolved with antiemetics at the
OSH. Nasogastric lavage was negative for blood.
Laboratory results revealed patient to have markedly
elevated prothrombin time (PT) and activated partial
thromboplastin time (aPTT) with an INR greater than
20. The patient was initially treated with fresh frozen
plasma (FFP) and high doses of vitamin K. The patient
denied any warfarin use and she did not know anyone
currently on the medication. CT scan of the head showed
left subdural hematoma without midline shift or
hydrocephalus. The patient was immediately transferred
to the Jefferson Neurosurgical service. The patient was
subsequently deemed a poor surgical candidate and was
continued on supportive treatment with blood products
and vitamin K. At time of transfer to the medicine
service, the patient developed respiratory distress with
severe hypoxia requiring intubation. The patient was
admitted to the intensive care unit (ICU) for ventilatordependent respiratory failure secondary to Transfusion
Related Acute Lung Injury (TRALI). After five days, the
patient was extubated and transferred to the medicine
floor team in stable condition for further management
of her bleeding diathesis.
The patient’s past medical history was significant only
for hypercholesterolemia but the patient was on no
medications. The patient had a cholecystectomy 12 years
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ago and a laminectomy 7 years ago. Psychiatric history
was notable for depression with prior suicide attempt five
years prior to admission. Family history was negative for
any bleeding disorder or malignancy. Social history
revealed no alcohol use, substance use, or smoking. The
patient was a homemaker.
On physical exam after transfer from the ICU, the
patient was afebrile with a pulse of 85 beats per minute,
a respiratory rate of 16 breaths per minute, and a blood
pressure of 132/72mmHg. In general, the patient was in
no acute distress. She was well nourished, well developed,
and appeared her stated age. The patient’s head was
normocephalic and atraumatic. Her eyes showed equally
round and reactive to light pupils and anicteric sclera.
Her extra-ocular muscles were intact. Her mucous
membranes were moist, her oropharynx was clear, and
there were no petechiae or stomatitis in the oral cavity.
Her neck was supple with no lymphadenopathy, no
thyromegaly, no JVD or carotid bruits. Her heart was
regular with no murmurs, gallops, or rubs. Her lungs
had minimal scattered bilateral rales and mild bibasilar
crackles. Her abdomen was soft, non-distended, nontender. There were no appreciable masses or
organomegaly. Her rectal exam revealed moderate
external hemorrhoids. There was normal rectal tone,
stool was dark brown and heme positive. There was no
frank blood. There was no clubbing, cyanosis, or edema
in the extremities. Her neurologic exam revealed no focal
deficits with cranial nerves II-XII grossly intact. There
was also no nystagmus, no dysmetria on finger to nose,
and deep tendon reflexes were equal and symmetric. Her
skin revealed small ecchymoses on upper extremities. See
Table 1 for the baseline laboratories at time of transfer to
the medicine floor service.
The remainder of the hospital course was notable for the
continued elevations in her PT. Multiple transfusions of
FFP and multiple injections of high-dose vitamin K
initially normalized the PT and aPTT at the time of
transfer from the neurosurgical service. Subsequent
coagulation labs revealed a continually rising PT
requiring the titration of the vitamin K dose from 10mg
daily to 50mg twice daily. For two weeks, the patient had
high doses of vitamin K and any dose
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Table 1.
Laboratory Test
White blood cells
Hemoglobin
Hematocrit
Platelet count
Sodium
Potassium
Chloride
Bicarbonate
BUN
Creatinine
Glucose
Protein
Albumin
Total biliribuin
AST
ALT
Alkaline phosphatase
PT
INR
aPTT

Table 2.
Laboratory Value
6.7
9.3
28.3
212
147
3.7
111
29
8.0
0.9
104
7.0
4.0
0.9
26
21
80
24.6
2.08
38.0

taper led to a rapid rise in PT (See Table 2). The platelet
count remained stable and hemolysis labs were negative.
Her DIC panel revealed a mildly elevated D-dimer and
a markedly elevated fibrinogen. Mixing studies
performed on the second day of admission revealed
normalization of elevated coagulation factors with
mixing indicating a deficiency of factors rather than a
presence of an inhibitor. Despite the elevated PT, there
was no further evidence of active bleeding during the
remainder of the hospitalization. Repeat head CT
revealed a slowly resolving subdural hematoma and the
hemoglobin remained stable. The patient was seen by
gynecology and gastroenterology but no active
interventions were planned as an inpatient.
Of concern was the patient’s psychiatric history with a
prior suicide attempt. The patient was initially placed on
one to one nursing especially given the continuing
elevations in her hemostatic labs. The patient repeatedly
denied depression or suicidal ideations. She was evaluated
by the psychiatry department at Jefferson and was deemed
safe for discharge home. Approximately one month after
discharge, the patient’s PT was stable on oral vitamin K.

Day 1

Day 2

Day 3

Day 4

Day 6

Day 7

Day 31 Day 32

PT

12.6

29.1

18.2

25.2

24.6

31.7

14.6

14.6

INR

1.0

3.47

2.45

5.17

2.08

2.88

1.07

1.07

aPTT

41.3

40.9

43.6

46.1

38

45

40mg

50mg

100mg 100mg 20mg** 20mg**

PT mix

13.1

aPTT mix

32.7

Daily Vit
K dose 10mg

20mg

* Transfer to the medicine floor

**Oral dose

Discussion
The history and presentation of the patient suggest a
diagnosis of an acquired hemostatic disorder rather than
an inherited or congenital disease. The patient did not
have any memorable episodes of bleeding in her past and
no one in her family had a problem with bleeding that
she could report. Acquired bleeding diathesis can be
categorized into two major categories, platelet defect
versus coagulation disorder.
A quantitative platelet disorder can induce bleeding
usually with platelet counts below 50,000. Diseases such
as idiopathic thrombocytopenic purpura (ITP),
thrombotic thrombocytopenic purpura (TTP), or
heparin induced thrombocytopenia (HIT) can
precipitously drop the platelet count. The patient did
not have a significant decline in her platelet count, nor
did she show any clinical signs of TTP (mental status
changes, fever, renal failure, hemolytic anemia). The
patient had also never been on heparin. A qualitative
platelet dysfunction can be medication-induced (ASA,
NSAIDs, clopidogrel, ticlopidine), or associated with a
medical condition such as uremia, myelodysplastic
syndrome (MDS), or von Willebrand disease (VWD).
The patient was not on any medications and had good
renal function. The diagnosis of MDS can be one of
exclusion especially when an elderly patient presents with
anemia (typically macrocytic) or pancytopenia with no
clear etiology. Diagnosis was not pursued because of low
clinical suspicion and a bone marrow biopsy was clearly
not indicated in this case. VWD is the most common
inherited bleeding disorder with a prevalence of
approximately 1%. A negative family history does not
rule out VWD since the clinical presentation can be
variable and subclinical. Most women with milder VWD
(Continued on next page)
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will usually report heavy menstrual periods and postpartum bleeding. The patient presented with heavy
bleeding for three days of sudden onset. Inherited VWD
would be very unlikely in this case since more severe
forms of VWD would manifest at a much earlier age.
Acquired VWD is a possibility but the disorder is
associated with comorbidities such as malignancies and
autoimmune disorders that were not evident in the
patient. Furthermore, VWD can cause an elevation of
the aPTT because it is the carrier of factor VIII, but it
will not cause critical elevations of PT and aPTT.
Ristocetin cofactor assay to test qualitative function of
von Willebrand factor was not performed.
Acquired coagulation disorders with elevated PT and
aPTT can be caused by liver disease, deficiency or
inhibitors to factor V or X, deficiency of fibrinogen or
prothrombin, disseminated intravascular coagulation
(DIC), or high doses of warfarin with or without
heparin. Vitamin K deficiency alone would not cause
elevations in aPTT. The patient had normal liver
function and had mixing studies that normalized during
the hospitalization. A mixing study mixes the plasma of
the patient with elevations in PT or aPTT with plasma
that has normal coagulation function. A normalization
of the coagulation labs would indicate a deficiency of
factors that were replaced by the normal plasma whereas
a continued elevation in PT or aPTT would indicate the
presence of an inhibitor (antibody or medication). Acute
DIC is most commonly associated with trauma, sepsis,
or malignancy and treatment is aimed at the underlying
cause. Supportively, the patient can be treated with FFP
or cryoprecipitate if the fibrinogen is low. The patient
only had a mild elevation in the D-dimer (fibrin
degradation product) and elevation in fibrinogen (acute
phase reactant). There was no evidence of hemolysis and
the platelet count was stable.
The marked elevations in the PT and aPTT that
responded to vitamin K are most consistent with
warfarin toxicity. The patient denied any use of the
medication and she could not have ingested the drug
accidentally. Also concerning was the difficulty of
normalizing her coagulation defect even weeks after the
inciting event. Rodenticides are warfarin derivatives with
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extremely high potencies. They are designed to be
antagonists of vitamin K but they are much more fat
soluble and their half lives are many weeks compared to
the 2-3 days of coumadin. The patient had a urine test
performed during the hospitalization to detect levels of
the commonly used “super-warfarins” of rodenticides like
bromodiolone and difenacoum but the test result was
negative. Three weeks into the hospitalization, a serum
assay for a specific warfarin derivative called brodifacoum
was sent to an outside laboratory. The result was positive
for 0.1µg/mL. This chemical is a second-generation
anticoagulant with a half-life of 157 days. It is retained
in tissues at high rates and can remain in organ systems
for years. The chemical is rapidly absorbed by the gut
and quickly causes gastrointestinal hemorrhage. The
mystery of how the patient ingested rodenticide was
confounded by her psychiatric history of depression and
prior suicide attempt. She repeatedly denied suicidal
ideations and the psychiatry department did not feel she
was a threat to herself at this time. Criminal investigation
was discussed but quickly dismissed when the patient
clearly expressed her desire not to pursue inquiries. The
patient was discharged on day 32 with instructions for
close follow-up.
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Cambodian Monk with Malaise
Aditi Satti MD, PGY-3

A 26 year-old Cambodian monk presents with complaints
of a three week history of fatigue and malaise. The patient
reports that four days prior to presentation he developed
fevers to 103F, chills and a severe headache. The patient
reports that he had returned from Cambodia one week
prior to initiation of symptoms. He denies any sick
contacts and denies any neck stiffness, photophobia,
visual changes or abdominal pain. The patient does report
diarrhea for one week with approximately 8-10 bowel
movements per day. The patient denies any risk factors
for HIV. The patient had been seen in the Emergency
Department one day prior to admission. His temperature
was 102F, pulse was 110 beats per minute, respirations
were 20 breaths per minute and blood pressure was
110/80mm Hg. A lumbar puncture was performed,
blood cultures and stool cultures were sent. The patient
was discharged with a prescription for Percocet.
On the following day, the blood cultures yielded gram
negative rods. The cerebrospinal fluid (CSF) was sterile and
the patient was contacted and admitted to the hospital.
On examination, the temperature was 103.6F, pulse was
110 beats per minute, respirations were 18 breaths per
minute and blood pressure was 102/66mm Hg. The
patient had erythematous linear lesions on trunk and back,
sclera was anicteric and there was no lymphadenopathy.
Heart was regular without murmurs, lungs were clear to
auscultation and abdomen was benign without evidence
of organomegaly. Rectal exam was negative for occult
blood. Laboratory examination revealed a normal white
cell count. The patient’s chemistries were also within
normal limits. Liver tests revealed an AST and ALT of 219
and 192 respectively. Stool studies were negative and blood
parasite smear was negative.
During his hospitalization, the patient was started on
broad spectrum antibiotics and blood cultures grew out
Salmonella typhii.
Discussion
Typhoid fever is a systemic infection with the bacterium
S. typhi. Typhoid fever occurs mainly in the developing
world such as India and Vietnam where sanitary
conditions remain poor. Typhoid is usually contracted
by ingestion of food or water contaminated by fecal or
urinary carriers excreting S. typhi.
Salmonella organisms multiply within mononuclear cells
in the lymphoid follicles, liver and spleen. The most

common sites of secondary infection are the gallbladder,
Peyer’s patches and the bone marrow. The incubation
period is 7-14 days.
The clinical manifestations of typhoid start initially as
an asymptomatic period of 7-14 days. Patients then
develop fever and malaise, a dull frontal headache,
anorexia and nausea. A tender abdomen,
hepato/splenomegaly and a relative bradycardia are
common. The fever in typhoid is initially low grade but
rises progressively and by the second week is sustained.
Occasionally, patients may develop rose spots on the
abdomen and chest. Lab work usually reveals a normal
white cell count, normal hemoglobin and platelets. Liver
enzymes are usually two times the upper limit of normal.
The most important complications of typhoid are
intestinal perforation, encephalopathy, and gastrointestinal bleeding. Relapse usually occurs two to three
weeks after resolution of fevers and is usually milder than
the initial attack. Fatality rate is less than one percent.
Blood cultures are the standard diagnostic method of
detecting typhoid. They are positive in 60-80% of
patients with typhoid. Typhoid can also be detected in
the bone marrow with approximately 80-95% sensitivity.
Typhoid needs to be distinguished from other endemic
subacute febrile illnesses such as malaria, dengue,
brucellosis, leptospirosis and tuberculosis.
The introduction of chloramphenicol for the treatment
of typhoid transformed a debilitating disease into a
treatable one. The emergence of resistance to chloramphenicol and other antimicrobials has been a major
setback. The flouroquinolones are the most effective
drugs for the treatment of typhoid fever. Patients should
be treated for a minimum of 10-14 days. Third generation
cephalosporins are also effective. Choloramphenicol is
appropriate in areas where the bacterium is susceptible.
Control of typhoid required the provision of safe
drinking water, effective sewage disposal and hygienic
food preparation. The typhoid vaccine is recommended
for travelers to areas where typhoid is endemic.
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Weakness in a Young Man
Steve C. Tsai MD, PGY-3

A 39 year-old African-American male with past medical
history significant for uncontrolled hypertension presents
with a sudden onset of weakness and numbness on the
left side of his face, left arm, left leg, and right leg while
watching television twenty hours prior to presentation.
At that time, the patient did have a mild headache. The
patient initially thought that it was positional, but soon
realized that he could not move the affected extremities
at all. He also began to have some difficulty swallowing
and minor difficulties with speech as well.
Two hours after the initial onset of symptoms, the patient
was able to ambulate without difficulty. Shortly
afterwards, he regained function and sensation in his left
upper extremity. His dysarthria and dysphagia also
resolved but he had a persistent drooping of his left lip
with numbness on the left side of his face.
On review of systems, he admitted that he had run out
of medications 3 days prior to presentation. He had also
noted a rash on the lateral portion of his left upper
extremity but he did not recall when it started. The rash
was pruritic for 2 days and then resolved without further
treatment. The patient denied fevers, chills, neck pain,
visual changes, diplopia, tinnitus, dizziness, and
lightheadness. The patient had no urinary or bowel
incontinence.
His past medical history is significant for uncontrolled
hypertension with multiple visits to the emergency
department; atypical chest pain, with a normal stress test
2 years prior to admission; gastroesophageal reflux and
hiatal hernia; hepatitis A; a positive PPD, treated with a
full course of prophylactic isoniazid; superficial
perivascular lymphocytic dermatitis diagnosed in 2000,
currently stable; and condyloma acuminatum, excised by
urology five months prior.
His medications included atenolol 100 mg twice daily,
clonidine 0.1 mg twice daily, nifedipine (SA) 90 mg daily,
enalapril 20 mg daily, rabeprazole 20 mg daily, sertraline
50 mg daily, and hydrocortisone cream twice daily as
needed. He had a syncopal reaction to loratadine. The
patient does not drink alcohol. He has a positive smoking
history but he quit in 1999. He has never used illicit
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drugs. He was a former prison guard, served in the Navy
in the 1991 Persian Gulf War and is currently active in
the US Army. His father died in his 50s of prostate cancer.
Physical examination revealed a 39 year-old male in no
acute distress with an initial blood pressure of 204/106.
Vital signs were otherwise stable. The patient had
decreased sensation to pinprick and dull pressure on his
left face. The patient also had weakened muscles of
mastication on his left side and flattened left nasolabial
folds. His strength, sensation, and reflexes in his
extremities were all within normal limits. He had normal
Babinski reflexes bilaterally with normal gait. He also
had a hyperpigmented rash noted on his left upper
extremity and scars on the lateral aspect of the left neck
and on his right thigh from old stab injuries. His cardiovascular, pulmonary, abdominal, and extremity
examinations were benign. Fundoscopic examination
revealed changes attributable to hypertension but no
papilledema. His main facial findings are shown in
Figure 1. (Permission was granted by the patient prior to
the picture being taken; this is documented with the
paper chart from this admission).
Laboratory data was significant for a slight hypokalemia
(3.3mmol/L), elevated glucose (120mg/dL), an elevated
ALT (205U/L), and a normal complete blood count. A
CT of the head without contrast was obtained showing
no acute bleed or pathology. Initial ECG (Figure 2)
shows sinus rhythm with left ventricular hypertrophy
and left-sided/lateral strain.
He was initially admitted to the intensive care unit with
a presumptive diagnosis of transient ischemic attack
secondary to the presence of significant hypertension.
Appropriate measures were taken to reduce systolic
pressure. A neurology consult was obtained the next
morning that discovered that much of his recent Army
training had been in wooded areas. Although the
possibility of hypertensive stroke/TIA could not be
ignored, Lyme neuropathy and neurosarcoidosis were
now on the differential due to this new information.
Serum Lyme titers, as well as a lumbar puncture with
CSF Lyme titers and angiotensin-converting enzyme,
were recommended.

Case Reports

Figure 1

Figure 2

Serum Lyme titers were negative. A lumbar puncture
showed colorless, clear fluid with 6 RBCs, 2 WBCs (both
neutrophils), glucose 63mmol/L, and protein 5mg/L.
Gram stain and culture were negative for cells or
organisms. Titers for VDRL and HSV were both
negative. An ACE-I level from the cerebrospinal fluid
was within normal limits. However, Lyme titers from the
cerebrospinal fluid returned positive at 1:52 (nml 1:10).
An MRI was performed which demonstrated mild
enhancement near the location of the left seventh nerve.
The patient had been started on ceftriaxone because it
took several days for the Lyme titers from the
cerebrospinal fluid to return. His facial signs slowly
improved and eventually resolved over the next few weeks.
Neuroborreliosis is only seen in approximately 10 percent
of untreated Lyme disease. Clinical presentations are
variable but there are distinct time periods during which
they arise. Aseptic meningitis, cranial nerve palsy (usually
involving the facial nerve), and radiculoneuritis (severe
localized radicular pain or motor weakness, with variable
sensory deficits) usually occur during early disseminated

disease (1-3 months). Aseptic meningitis and peripheral
neuropathies may also occur with reactivated disease.
Headache and neck stiffness are usually mild. Asymmetric
dermatomal and myotomal abnormalities, also known as
lymphocytic meningoradiculitis or Bannwarth’s
syndrome, can be seen. These cases are usually seen in
Europe, although rare cases can be seen in North America.
Encephalopathy and chronic encephalomyelitis are
usually manifestations of late persistent infection (> 3
months). Neuroborreliosis is treated effectively with one
month of intravenous ceftriaxone. Oral doxycycline is an
option in isolated facial nerve palsy, but due to the severity
of cerebrospinal fluid inflammation, intravenous
antibiotics are usually preferred.
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What’s Your Diagnosis?

Lung Cavitary Lesion
Bassem Elgohary MD, PGY-3 and Betty Lim MD, PGY-2

A 35 year-old Caucasian woman with history of Systemic
Lupus Erythematous (SLE) complicated by Lupus
glomerulonephritis presented to the Emergency
Department complaining of worsening bilateral lower
extremity rash and leg pain. The rash had been present
for over a month and a recent biopsy of the lesion
revealed leukocytoclastic vasculitis. Her usual dose of
prednisone 120mg every other day had been increased
to 60mg daily over the past few weeks with the worsening
rash. In addition to the rash and leg pain, she also
reported some right-sided pleuritic chest pain.
Otherwise, the patient noted no shortness of breath,
cough, fevers, or chills. Of note, she was recently treated
for both pneumonia and a pulmonary embolism at an
outside hospital.
Past medical history for this patient was significant for
the diagnosis of SLE made six months prior along with
diffuse proliferative glomerulonephritis for which she
had undergone therapy with Cytoxan twice and Cellcept.
She was unable to tolerate either of these treatments and
was switched to oral prednisone. Two months ago, she
was started on intermittent dialysis via a permacath that
had been placed.
Physical exam on admission revealed an afebrile young
woman with stable vital signs who was visibly
uncomfortable due to the pains in her legs. She had
normal heart sounds with no murmurs or rubs. Her lung
exam was significant for decreased breath sounds over
the right lung base, but otherwise her lungs were clear to
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auscultation. Abdominal exam was unremarkable.
Examination of her lower extremities revealed macular
patches of an erythematous rash with scattered patches
of palpable purpura that were all tender to touch. Her
blood work was remarkable for a white blood cell count
of 28,000 with 97% neutrophils, platelets of 73,000,
hemoglobin of 10.2g/L, hematocrit of 34%, creatinine
of 2.2 mg/dL and a C-reactive protein of 4.8mg/dL.
The patient was admitted to the hospital and treated
with pain medications and high dose intravenous steroids
for her progressive vasculitis. The leg pain and rash
showed signs of improvement over the course of several
days, however she continued to complain of worsening
pleuritic chest pain. A chest X-ray (Figure 1) revealed a
right lower lobe opacity while a ventilation/perfusion
scan showed a low probability for pulmonary embolism.
CT scan of the chest without contrast (due to her
impaired renal function) was performed on day 6 of
hospitalization (Figure 2).
On day 7 of hospitalization, the patient developed
respiratory distress requiring emergent intubation.
Bronchoscopy was performed revealing copious amounts
of purulent secretions in the right main-stem bronchus
along with its associated branches. An ultrasound-guided
thoracentesis of the right side was performed and the
fluid was sent for analysis. Figures 3 and 4 show two
stains that were obtained from pleural fluid specimen.
Please also see inside front cover for another pleural fluid
specimen.

What’s Your Diagnosis?

Figure 1 – Chest X-ray – Right lobe opacity

Figure 2 – Non-contrast CT of the chest – multiple nodular air
space consolidations in the right middle and right lower lobe
with cavitation at the right base.

Figure 3 – Gram stain from pleural fluid specimen. Delicate
filamentous gram positive rods are seen.

Figure 4 – Modified Acid-Fast Stain (Kinyoun) from pleural
fluid specimen. Gram positive branching filamentous rods that
are partially acid fast.

What’s Your Diagnosis?
Turn the page for the diagnosis and discussion.
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What’s Your Diagnosis?

(Continued from previous page)

Diagnosis: Nocardia
Nocardia is part of the actinomyces species which
includes Mycobacterium and Actinomyces. They are
considered aerobic bacteria which appear as filamentous,
branching gram-positive rods on gram stain. In contrast
to Actinomyces, Nocardia species are positive by modified
acid-fast stains (Kinyoun stains) secondary to the mycolic
acid content in their cell walls.
Nocardia is found worldwide in the soil, decaying
vegetable matter, and aquatic environments. It can
become airborne and ultimately inhaled or directly
inoculated as a result of trauma, surgery, catheters, or
animal bites and scratches. Initially, the host response
involves neutrophils and macrophages engulfing the
bacteria. Then a T cell-mediated response occurs which
enhances this phagocytic process and helps eliminate the
bacteria. Since cell-mediated immunity is so important,
Nocardia causes disease mainly in immunocompromised
individuals such as those with HIV/AIDS, prolonged
steroid use, hematological malignancies, transplant
recipients, and even diabetics and alcoholics (~ 60% of
cases). However, nocardiosis can also occur in those with
intact immune systems (~ 40% of cases).
Nocardia is known for its ability to affect any organ
system. The most common organ involved is the lung,
followed by skin and then central nervous system (CNS).
Lung involvement can be acute, sub-acute, or chronic
and manifested by a variety of symptoms such as cough,
SOB, fevers/chills, night sweats, hemoptysis, or pleuritic
chest pain. Imaging studies may reveal lobar
consolidation, interstitial infiltrates, single or multiple
nodules, lung masses (with or without cavitations), or
pleural effusions. Skin involvement is also diverse and
can be manifested by cellulitis, ulcerations, pyoderma, or
subcutaneous abscesses. CNS involvement occurs as a
result of special affinity of Nocardia to neuronal cells and
results in brain abscesses with signs and symptoms such
as headaches, fevers and chills, meningismus, seizures,
and focal neurological deficits.
There have been no prospective randomized trials ever
performed to determine what the best treatment options
are for nocardial infections. Most of the data in the
literature stem from experienced clinicians,
microbiology/antibiotic studies, and animal models. The
antibiotic of choice is trimethoprim-sulfamethoxazole
(TMP-SMX) which has good tissue penetration
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including the CNS. Other agents include amikacin,
imipenem, 3rd generation cephalosporins, and
minocycline. In addition to antibiotics, surgical
intervention is necessary for any abscesses.
Former cases of nocardiosis suggest it has a tendency to
relapse, but those treated for a prolonged period of time
can achieve complete remission. It is recommended that
immunocompetent patients with pulmonary or nonpulmonary involvement, other than CNS, be treated for 6
months. Patients who are immunocompromised or have
CNS involvement should be treated for 12 months. Cure
rates depend on the virulence of the Nocardia species and
the host immune response, but in general: skin ~100%,
pulm ~90%, non-pulm/non-CNS ~60%, and CNS ~50%.
Discussion
Our young patient fits the profile of those who become
susceptible to disseminated nocardiosis. She was indeed
immunocompromised not only from her chronic high
dose steroid use but also from her past exposure to
Cytoxan and Cellcept therapies. The fact that the
organisms were so readily visualized by gram stain from
pleural fluid samples emphasizes the large organismal
burden as well as its dissemination. Upon modified acidfast stain confirmation, the patient was started on high
dose TMP-SMX. Since speciation and sensitivities were
still pending at that time, she was also started on
combination therapy with ceftriaxone and linezolid. The
organism was eventually confirmed as Nocardia asteroides
sensitive to TMP-SMX. Ceftriaxone was stopped but
linezolid was continued for possible synergy in
combination therapy as had been recently reported. A
chest tube was placed on the right lung for drainage of
the purulent effusion. Three days after being intubated,
the patient was extubated without complications. A head
CT showed no signs of any intracranial cavitary lesions.
Her steroid regimen was quickly tapered over the next
two weeks and all plans for restarting Cytoxan treatment
were put on hold. On day 24 of hospitalization, the
patient was discharged home on oral prednisone 5mg
twice a day, oral linezolid 600mg twice a day, and TMPSMX DS two tablets twice a day.
Reference
1. Chapman S. Diagnosis and treatment of nocardiosis.
UpToDate version 12.2.2004. Available at
www.uptodate.com. Accessed October 2004.
2. Moylett et al. Clinical Infectious Diseases. 36(3):313-8, 2003.

What’s Your Diagnosis?

Hematology Slide Review
Jane Choi MD, PGY-2

On physical exam, the patient is afebrile and vital signs
are stable. She is a well-developed, healthy female in no
acute distress. Multiple petechiae are noted on her upper
extremities and anterior chest wall. Several ecchymoses
are present over sites of blood draws. The spleen tip is
felt approximately 2cm below the costal margin. She is
hemoccult negative rectally. The rest of the physical exam
is within normal limits.
Labs reveal white blood count 8,200, hemoglobin level
of 7,900 and platelet count of 16,600.
Below are her blood smears. What’s Your Diagnosis?
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ALL - acute lymphoblastic leukemia

A 23 year-old Caucasian female with no past medical
history presents with one week of easy bruising and
increasing “red spots” on her arms and chest. She does
not recall any history of trauma that may have lead to
the bruises. She denies any fever or chills. She has no
history of bleeding problems and underwent dental
procedures last year without any complications. On
review of systems, she had vague left abdominal pain over
the past week and 3 days of right ear pain that was
recently treated with cefuroxamine as directed by her
primary care doctor. Family history is noncontributory.
She drinks occasional alcohol on weekends and denies
any tobacco or drug use. She takes no medications.

Images In Medicine

Pseudomyxoma Peritonei
Erev E. Tubb MD, PGY-3

The patient is a 78 year-old male with
a past medical history of
hypertension and duodenal ulcer
presenting with 2 months of
increasing abdominal girth. The
patient reports 1 month of loose
bowel movements and a 2 week
history of early satiety. He notes that
in the last week he has been nauseous
at the smell and thought of food. He
denies fevers, chills, excessive alcohol
intake, history of blood transfusions,
intravenous drug use, melena or
bright red blood per rectum. The
patient states he has never undergone
a colonoscopy and to his knowledge
there is no family history of
malignancy.
The patient was admitted to the
hospital and a diagnostic study was
performed. The images from a CT
scan demonstrate multiple loculated
fluid collections with enhancing
walls within the peritoneal cavity.
The largest mass was located
anteriorly within the peritoneal
cavity and measured 30cm x 14 cm
(transverse x AP) and extended from
the liver to the bladder. These
finding were consistent with a
pseudomyxoma peritonei and the
patient was taken to surgery for an exploratory
laparotomy. The patient underwent an evacuation of the
gelatinous tumor and an ileocecal resection with
primary ileoascending colostomy. The pathology report
revealed the origin of the mucinous secretions was in
fact an appendiceal cystadenocarcinoma.
Pseudomyxoma peritonei is a rare condition resulting
from rupture of a mucocele of the appendix, a mucinous
ovarian cyst, or mucin-secreting intestinal or ovarian
adenocarcinoma. It is two to three times more common
in females than in males. It is often an unexpected
finding during a laparotomy and is said to be found in 2
of every 10,000 laparotomies.
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The primary treatment remains
surgical debulking although the rate of
recurrence in the twelve-year Mayo
Clinic series was 76% with 50% of
recurrences in the first 2.5 years. It is
not clear if adjuvant radiotherapy
and/or chemotherapy is beneficial.
The five-year survival rate ranges from
53 to 75%, but outcomes vary widely
between relatively benign and
malignant subgroups. Patients with
appendiceal
cystadenocarcinomas
with pseudomyxoma peritonei have a
25% five-year survival rate, with most
deaths attributed to intestinal
obstruction or renal failure. The study
of pseudomyxoma peritonei is limited
by the rarity of the condition and the
small number of cases collected in
published series.
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Small Bowel Varices Without Esophago-gastric Varices:
A Cause of Massive Gastrointestinal Hemorrhage
Sivakumar Srinivasan MD, PGY-3 and Kuntal Thaker MD, PGY-6, Gastroenterology Fellow

The following case demonstrates small bowel varices
without esophago-gastric varices as an unusual cause
of gastrointestinal bleeding in a patient with chronic
liver disease.
The patient is a 47 year-old man who presented to the
hospital with several days of back pain and weakness.
The work-up of his symptoms revealed a L3-L4
phlegmon on MRI of the lumbar spine. A biopsy of this
lesion yielded focal nonviable bone.
The day after his biopsy, the patient was noted to have
two episodes of melena followed by bright blood mixed
with stool. The patient complained of some lightheadedness.
His medical history included cirrhosis from alcohol,
hepatitis C and hypertension. He drank six to ten cans
of beers a day and smoked half a pack of cigarettes a day.
He quit intravenous heroin ten years prior to admission.
The patient noted no allergies and was maintained on
lactulose, furosemide, and spironolactone at home.
Vancomycin was started in the hospital.
On examination, the patient’s temperature was 97.2F
orally, pulse was 106 beats per minute, respirations were
16 breaths per minute, and blood pressure was 140/78
mmHg. The patient appeared comfortable. He had pale
conjunctivae and scleral icterus, heart was tachycardic,
lungs were clear, abdomen was mildly distended and
non-tender with normal bowel sounds. There was no
abdominal ascites and there was trace pitting edema. The
rectal exam revealed bright red blood. The patient was
promptly transferred to the intensive care unit.
Laboratory values revealed that the hemoglobin decreased
from 8.8g/dL to 4.4g/dL. The patient’s platelets were
93,000/mm3. The chemistry panel was normal and the
liver function tests showed protein 2.9g/dL, albumin
2.0g/dL, total bilirubin 2.7mg/dL, direct bilirubin
1.4mg/dL, aspartate aminotransferase 89U/liter, alanine
aminotransferase 38U/liter, and alkaline phosphatase
34U/liter. The prothrombin time was 20.1 seconds,
partial thromboplastin time was 38 seconds, and the
international normalization ratio was 1.56.
A prompt bedside nasogastric tube lavage revealed bilious
aspirate. The patient was transfused with four units of
packed red blood cells (PRBCs) and eight units of fresh
frozen plasma without a change in his hemoglobin.
Bedside upper endoscopy revealed no esophageal varices

Figure 1

or other sources of bleeding. He was transfused with an
additional four units of PRBCs with an increase in
hemoglobin to 7.6g/dL. Although hemodynamically
stable, he continued have bright red blood per rectum
and a decision was made to proceed with an angiogram.
The angiogram revealed no site of arterial extravasation
during superior mesenteric and celiac arteriography.
Several clusters of varices within the small bowel were
deemed to be the bleeding sites. (Figure 1)
Emergent transjugular intrahepatic portosystemic shunt
(TIPS) was placed to decompress the small bowel varices.
This produced a reduction in the mean portosystemic
gradient from 33 to 9mmHg. The patient received an
additional seven units of PRBCs during the procedure.
Over the next two days, the patient continued to have
melena and required an additional six units of PRBCs.
Patient’s bleeding subsequently ceased and he remained
stable for seven days after the TIPS procedure.
Unfortunately, on the eighth day after the TIPS
procedure, he developed Staphylococcus aureus sepsis
leading to hemodynamic compromise and death.
This case demonstrates that in patients with cirrhosis and
gastrointestinal hemorrhage, non-traditional bleeding
sources, such as small bowel varices, should be considered
in the absence of esophago-gastric varices.
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Bronchiectasis
Jane Luu, 4th Year Medical Student

A 43 year-old Chinese woman who
immigrated to the United States in
1994 was seen because of several years
of chronic, intermittent coughing
that was productive of voluminous,
thick, green sputum with occasional
blood streaking. The cough was
accompanied by right anterior
pleuritic chest pain. She had no
fevers, chills, or night sweats. Her
medical history included childhood
pneumonia at the age of 18 months,
a prior right pneumothorax that
required chest tube placement, and a
positive PPD. She was a nonsmoker.
Despite her symptoms, she was fully
functional with activities of daily
living but unable to tolerate exercise.
She worked as a part-time seamstress
and had no environmental exposures.
Review of systems was significant
only for a 20lb weight loss in the past 2 years.
On exam, she was a thin Asian female weighing 94 lbs in
no acute distress and with no labored breathing. On lung
auscultation, crackles were heard diffusely and, at the
right upper lobe, adventitial sounds and a pleural friction
rub were also appreciated. She had no lymphadenopathy
and physical exam was unremarkable otherwise.
Bronchoscopy and sputum analysis were performed.
Bronchial brushings showed mucopurulent secretions in
the right upper lobe, but both bronchial samples and
sputum samples were negative for acid fast bacilli (AFB).
Heavy growth of Pseudomonas aeruginosa was seen in
both sputum and bronchoscopy specimens. CT scans of
the thorax were obtained and are shown above.
The patient’s CT scans showed extensive dilatation of
the bronchi throughout the entire right lung with
thickening of the bronchial walls. Air fluid levels can also
be seen, suggesting mucous secretion entrapment in the
dilated airways. The lung parenchyma is fibrosed and
collapsed with large bullae occupying the lung base.
Bronchiectasis is a disease defined by its morphology; the
irreversible dilatation of bronchi damaged from a
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primary insult such as infection
(MAI, pneumonia, pertussis),
hypersensitivity reaction (ABPA),
cystic fibrosis, primary ciliary
dyskinesia, or congenital airway
obstruction. The primary disease
promotes infiltration of the area with
neutrophils and T-lymphocytes, with
increased release of elastase, IL-8,
TNF-a, and prostanoids. The
resulting inflammation leads to
further obstruction and damage of
the bronchial airways, thereby
initiating a new cycle of
inflammation and bronchial wall
injury. Symptoms include chronic
cough, hemoptysis, foul-smelling
sputum, and dyspnea.
Management consists of antibiotics
to control acute infections; P.
aeruginosa, H. influenza, S.
pnemonia, and MAI are common pathogens. Inhaled
corticosteroids and bronchodilators can help relieve
symptoms by reducing airway inflammation. Chest PT
and postural drainage help address the issues of mucous
overproduction. There are reports of successful surgical
outcomes if bronchiectasis is unilateral, where removal
of the diseased lung can be curative in some patients.
The use of inhaled tobramycin in bronchiectasis is also
currently being studied. Initial studies have shown a
decrease in sputum P. aeruginosa in approximately 2/3 of
patients with minimal side effects; however, more studies
are needed to better assess its efficacy and long term
outcome.
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Clostridial Myonecrosis
Jaime Chin MD, PGY-3

A 48 year-old male with a past medical history of gout,
degenerative disc disease, and T cell lymphoma treated
with chemotherapy and autologous peripheral blood
stem cell transplant, currently in remission, presented
seven days status-post a non-myeloablative allogeneic
transplant with an acute onset of excruciating left hip
and groin pain and a low-grade fever. The physical exam
did not reveal any obvious cause of his extreme pain.
The CT imaging revealed extensive inflammation of the
left retroperitoneum and psoas muscle with a large focus
of gas. The patient was taken emergently for exploratory
surgery that revealed extensive myonecrosis of the left
psoas muscle with air and foul-smelling serous fluid. The
pathology of the surgical soft tissue specimen revealed
Clostridium perfringens.
Clostridial myonecrosis, also known as gas gangrene, is a
severe, rapidly progressive infection with devastating
results. It is usually the result of trauma or surgical
complication, but a small percentage of cases are
spontaneous. The spontaneous cases are often associated
with either a gastrointestinal malignancy, or in the case
of our patient, a hematological malignancy. Clinical
findings include severe pain out-of-proportion to
physical exam findings, low-grade fevers (less than 101F),
and tachycardia. The overlying skin may vary in color it may be completely unchanged, very pale, bronze in
color, or even a purplish-red color. These color changes
may also be associated with bullae. Gas may be palpated
in the tissues.

Complications
of
this
infection include a brisk
hemolysis, jaundice, liver
necrosis, shock, renal failure,
ARDS and death. The
mortality is 20-30% if the
infection occurs in an
extremity and is treated
rapidly and aggressively. However, truncal or
spontaneous cases are often associated with a mortality
of 67-100%, even with proper treatment. Treatment is
multifactorial and includes appropriate antibiotics,
usually penicillin and/or clindamycin. Aggressive surgical
debridement is essential. Hyperbaric oxygen therapy may
also be effective as an adjunct to antibiotics and surgery;
however, studies have failed to show a consistent benefit.
Mortality usually occurs within 24-36 hours of infection,
and even when the patient survives, severe disability
usually results from the numerous and radical surgeries
required to debride infected tissue.
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Ventricular Fibrillation or Not?
Parmatma Greeley MD, PGY-3

Mr. B is an 84 year-old African-American male veteran
with a history of type 2 diabetes and hypertension who was
admitted to the VA hospital for hypertensive urgency. In
the ICU, he became unresponsive and pulseless. Telemetry
showed “ventricular fibrillation” which spontaneously
converted to sinus rhythm. An echocardiogram showed an
ejection fraction of 60%. An ECG performed prior to the
ventricular arrhythmia is shown below.
The major findings of this ECG are bradycardia, QT
prolongation, U waves, and T wave alternans (TWA) best
seen in leads V3, V4, and V5. With these findings, it is
important to ask if the patient was really in ventricular
fibrillation.
Ventricular fibrillation rarely spontaneously remits. The
findings of QT prolongation and TWA prior to the event
are suggestive of a ventricular tachyarrhythmia. This
patient had normal electrolytes and was on no drugs that
typically cause QT prolongation. He was sent to a
hospital with an electrophysiology department and given
the diagnosis of long QT syndrome and TWA. Mr. B’s
risk of developing another tachyarrhythmia was
considered very high therefore an Automatic Implantable
Cardioverter Defibrillator (AICD) was placed.
TWA is a variation in the shape of the T waveform seen
every other beat representing a change in the intrinsic
repolarization of the heart. It is a highly sensitive and
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specific marker of susceptibility to ventricular
arrhythmias and sudden cardiac death. TWA often
precedes conditions like Prinzmetal’s angina, acute
myocardial infarction, electrolyte imbalances and long
QT syndrome. TWA is detected by measurement of
microvolt level. TWA on surface Laplacian ECG is
commonly associated with long QT syndrome. TWA
seen by the naked eye on ECG is a rare finding. Testing
for TWA may identify patients at increased risk who
fulfill MADIT II criteria for AICD placement.
Thank you to Dr. Reddy for this interesting ECG.
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Man with Syncope
Emily Lai MD, PGY-2 and Anita Mehrotra MD, PGY-1

Mr. K, a 57 year-old Caucasian male with a history of
coronary artery disease, dilated ischemic cardiomyopathy, ventricular fibrillation arrest status post
implantable cardioverter defibrillator (ICD) placement
was admitted to telemetry for two syncopal episodes. The
patient described multiple episodes of dizziness with
fatigue over the week prior to admission, the last two
episodes resulting in loss of consciousness with bladder
incontinence. He was home alone when these episodes
occurred and was unsure of how long he had been
unconscious. Mr. K was not aware of any recent firing of
his ICD. He denied any shortness of breath, chest pain,
diaphoresis, recent fevers or chills.
His medical history was significant for hypertension,
coronary artery disease status post two vessel coronary
artery bypass grafting, dilated cardiomyopathy, and
ventricular fibrillation arrest with subsequent ICD
placement four years ago. His most recent echocardiogram was four years ago, showing an ejection fraction
of 15%. The patient’s medications included enalapril,
carvedilol, amiodarone, warfarin, ezetimibe, digoxin,

atorvastatin, furosemide, aspirin and niacin. He had no
known drug allergies. Mr. K was a retired train
conductor. He smoked half of a pack of cigarettes a day
and had an 80 pack-year smoking history. He had a
history of alcohol, cocaine, and amphetamine abuse, but
he quit these drugs 15 years prior. He denied any history
of intravenous drug use.
Physical examination on admission was significant for
elevated jugular venous pressure, a grade II/VI systolic
ejection murmur over the left sternal border, diffuse
wheezes on lung exam, and 2+ lower extremity edema.
Laboratory results showed a B-type natriuretic peptide
level of 662 pg/ml, a creatinine of 1.0 mg/dL, and a
digoxin level of 1.6 ng/mL. Chest X-ray showed
moderate pulmonary edema. His electrocardiogram
(ECG) is shown in Figure 1.
The patient was admitted to telemetry and ruled out for
myocardial infarction by serial enzymes. His ICD was
interrogated on hospital day 1, revealing three episodes
of ventricular tachycardia, which correlated with his

Figure 1
(Continued on next page)
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symptoms. The settings of his ICD were adjusted, and
the electrophysiology service recommended reloading
the patient with oral amiodarone. The patient was
started on amiodarone 400 mg three times a day for the
next five days. For treatment of his congestive heart
failure exacerbation, the patient was diuresed with
intravenous furosemide with a goal negative balance of
one to two liters per day. The patient was also started
on nebulizers for suspected chronic obstructive
pulmonary disease and spironolactone to optimize his
heart failure regimen. The patient reported feeling
improvement over the next four days.
On the morning of hospital day #5, Mr. K complained
of feeling very uncomfortable with a sensation of fullness
and bloating in his abdomen, which the patient
attributed to being constipated. He reported no bowel
movements in the past few days. He also complained of
increased weakness, shortness of breath and an episode
of chills, nausea and emesis overnight. On physical exam,
he was afebrile, heart rate was 60 beats per minute and
blood pressure was 124/77 mmHg. His abdomen was
distended but nontender with active bowel sounds. No
rebound or guarding was present. An arterial blood gas
was attempted but was felt to be venous. The pH of the
venous blood gas was 7.37. Stool softeners and laxatives
were ordered and an extra dose of furosemide was given.
A few hours later, the patient called the nurse complaining
of feeling poorly. The nurse noted the patient to be
diaphoretic and cyanotic. She attempted to take his blood
pressure and could not detect a pressure by manual cuff.
The primary team was called to evaluate the patient and
detected a systolic blood pressure of 54 mmHg by doppler.
A fluid bolus of one liter of normal saline was given with
improvement of the systolic blood pressure to 82 mmHg
by doppler. The patient complained of an uncontrollable
gasping for air but denied any chest pain. Central venous
access was obtained, and the critical care unit team was
called to evaluate the patient for hypotension and cyanosis.
Physical examination revealed the patient to be alert in
moderate distress with cyanotic lips. After a one liter fluid
bolus, the patient had a heart rate of 70 beats per minute
and respirations were 30 breaths per minute. A pulse
oximetry reading was unobtainable due to cyanotic
extremities. Jugular venous pressure was estimated at
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10mmHg. The systolic murmur was unchanged from prior
exams. Lung exam demonstrated wheezes diffusely with
1+ lower extremity edema. A stat echocardiogram was
ordered to evaluate the possibility of cardiac tamponade
given the patient’s hypotension. Echocardiogram showed
an ejection fraction of 10%, severe left ventricular
enlargement with global dysfunction, mild to moderate
mitral regurgitation, but no pericardial effusion.
An electrocardiogram was obtained and is shown in
Figure 2. Compared to his previous ECG on admission
which showed mostly ventricular paced beats, the patient
now had a sinus rhythm with widened QRS complexes
(duration 640ms) and peaked T waves. Hyperkalemia
was suspected, and the patient was given two ampules of
calcium gluconate and 10 units of insulin intravenously
with one ampule of dextrose 50%. The patient’s blood
pressure fell to the 70s/40s mmHg and continous
dopamine infusion was started. The patient was placed
on a 100% non-rebreather mask and urgently transferred
to the cardiac intensive care unit.
Stat laboratory results returned showing the serum
potassium to be 6.8 meq/L (compared to 4.0 meq/L the
day before), serum bicarbonate of 19 meq/L (previously
31 meq/L), calcium 2.0 mg/dL (from 4.2 mg/dL) and
creatinine of 1.7 mg/dL (from 1.0 mg/dL). The patient
was given three more ampules of calcium gluconate and
two ampules of sodium bicarbonate for his hyperkalemia.
Approximately 10 minutes after arrival to the CCU, the
patient began to complain of extreme shortness of breath.
His heart rate rapidly decreased to the 50s, and the
patient became unresponsive and pulseless.
Cardiopulmonary resuscitation was initiated for pulseless
electrical activity and three doses of epinephrine were
given. The patient’s rhythm converted to pulseless
ventricular fibrillation, and defibrillation was attempted
three times without change in rhythm or recovery of
pulse. An intravenous bolus of amiodarone was also given
without any response. Resuscitative efforts were
continued for 20 minutes before the patient was
pronounced dead.
Discussion
Post-mortem, a serum digoxin level sent earlier that
morning showed a level of 5.8 ng/ml. This level was well
above the upper limit of therapeutic (0.5 to 2 ng/ml).
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Figure 2

Digoxin toxicity was likely a contributing factor in this
unfortunate case. The patient had multiple known risk
factors for digoxin toxicity, including cardiac disease,
potential electrolyte abnormalities from diuresis, acute
renal insufficiency, and the addition of medications that
interfere with digoxin metabolism.
Digoxin acts by inhibiting the sodium-potassium
adenosine triphosphatase (ATP-ase) pump in myocytes.
With each action potential, sodium enters but a
decreased amount of sodium exits leading to an increase
in intracellular sodium and a decrease in intracellular
potassium. Through the sodium-calcium exchange, the
increase in sodium results in increased intracellular
calcium. This increases myocardial contractility and
enhances automaticity while slowing conduction
through the atrioventricular node. The decrease in
intracellular potassium may cause a relative increase in
extracellular potassium leading to elevated serum
potassium levels.
The most important method of diagnosing digoxin
toxicity is to maintain a high level of suspicion. Signs
and symptoms of digoxin toxicity are often subtle and
nonspecific. Patients may experience nausea, vomiting,

abdominal pain, fatigue, blurred vision, headache,
dizziness, confusion, delirium, and altered color vision
(classically described as seeing yellow halos around
lights). No single ECG abnormality is pathognomonic
of digoxin excess. However, the combination of
enhanced automaticity and impaired conduction (e.g.,
atrioventricular (AV) block accompanied by an
accelerated junctional pacemaker) is highly suggestive of
toxicity even when serum levels are within the “accepted”
therapeutic range. The first presenting sign of digoxin
toxicity may be a cardiac arrhythmia. Almost any
arrhythmia may be associated with digoxin toxicity,
though the most frequent is ventricular ectopy. Sinus
bradycardia, sinus arrest, paroxysmal atrial tachycardia,
heart block, junctional rhythms, ventricular tachycardia
and fibrillation are also commonly seen.
Digoxin is excreted through the kidneys proportional to
the glomerular filtration rate and is therefore dependent
on creatinine clearance. Renal insufficiency is then a
predisposing factor for digoxin toxicity. In our patient,
the acute renal insufficiency was likely secondary to
aggressive diuresis.

(Continued on next page)
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Table 1. Commonly Used Medications that Affect Digoxin Level
Drug

Effect

Mechanism

Amiodarone
Verapamil
Diltiazem
Spironolactone
Indomethacin
Cyclosporine
Tetracycline
Cholestyramine
Rifampin

Increases
Increases
Increases
Increases
Increases
Increases
Increases
Decreases
Decreases

↓ renal clearance
↓ renal clearance
↓ renal clearance
↓ renal clearance
↓ renal clearance
↓ renal clearance
Altered gut flora
↓ gut absorption
Induction of
gut P-glycoprotein

Amiodarone, among many other drugs, is known to
increase serum digoxin levels though decreased renal
excretion at the tubular level and may also displace
bound digoxin from tissue. (See Table 1 for a list of other
commonly used medications that affect digoxin levels.)
It is recommended that patients being started on
amiodarone should have their maintenance doses of
digoxin decreased by 50 percent with close monitoring
of serum digoxin levels. In our patient, his maintenance
digoxin dose while on amiodarone 200 mg daily was
0.25 mg with a digoxin level within therapeutic range
(1.6 ng/mL). He was also started on spironolactone
during his hospitalization, which like amiodarone,
increases digoxin levels by decreasing renal clearance. The
patient’s rapid increase in serum digoxin level was likely
due to decreased renal excretion from the combination
of the oral amiodarone load, the addition of spironolactone, and acute renal failure.
As previously mentioned, digoxin toxicity may also be
associated with hyperkalemia by inhibiting sodiumpotassium exchange into the myocyte. In this case, Mr.
K had three potential causes of hyperkalemia: acute renal
failure, spironolactone use, and digoxin toxicity. The
treatment he received for his hyperkalemia included
multiple ampules of calcium gluconate which may have
further potentiated the effects of digoxin.
Elevated serum calcium levels increase ventricular
automaticity and this effect is at least additive to, and may
be synergistic with, the effects of digoxin. Administration
of intravenous calcium to patients taking digoxin may
provoke lethal ventricular arrhythmias, in particular,
refractory ventricular tachycardia and fibrillation. Thus,
calcium gluconate administration is problematic in
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hyperkalemia if digoxin toxicity is suspected and generally
not recommended. In Mr. K’s case, the cause of his cardiac
arrest may have been primarily hyperkalemia which would
correlate with his rhythm of pulseless electrical activity.
However, his rhythm then converted to ventricular
fibrillation that was unchanged after multiple attempts at
defibrillation. This may have been the effect of the five
ampules of calcium gluconate that were unknowingly
administered in the context of digoxin toxicity.
In severe cases of digoxin toxicity, digoxin-specific
antibody fragments (Digibind) may be used to treat
patients. Digibind rapidly binds circulating digoxin (as
digoxin has an increased affinity for the antibody fragment
over the sodium-potassium pumps) thus inactivating the
drug. Indications for use of Digibind include an acute
ingestion of greater than 10 mg of digoxin, plasma digoxin
levels greater than 10ng/ml, and potassium levels greater
than 5meq/L in the presence of a life-threatening
arrhythmia, as in this case. The antibody fragments are
given intravenously over 30 minutes, unless cardiac arrest
has occurred, in which case the solution is given as a bolus.
Side effects are few with Digibind but include worsening
congestive heart failure and hypokalemia.
Would the outcome of Mr. K’s case have been different
if digoxin toxicity had been suspected and Digibind
administered? We hope that by highlighting this case of
digoxin toxicity with associated hyperkalemia, we will
heighten awareness for the diagnosis and never have to
ask ourselves this question in the future.
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Effect Of Endogenous Noradenaline Release On Peak Exercise Heart Rate
In Subjects With Chronic Heart Failure Receiving Carvedilol Versus Metoprolol
Timothy J Vittorio1, Duygu Onat2, Paolo C Colombo2, John Stathopoulos2, Cselaj Sulejman2,
Andrew B. Rose2, Gillian Miller2, Joshua Trufant2, Rochelle Goldsmith2 and Ulrich P Jorde1
1
Medicine, Heart Failure Program, New York University School of Medicine, New York, NY, 10016
2
Medicine, Columbia University College of P&S, New York, NY, 10032

Background
Dose equivalency of metoprolol and carvedilol for beta1 blockade remains subject of ongoing debate. The
degree of beta-1 blockade is best assessed in vivo by
blunting of the exercise induced heart rate. Accordingly,
we examined baseline and peak exercise heart rate in
subjects with chronic heart failure (CHF) treated with
carvedilol or metoprolol. To correct for possible
differences in norepinephrine (NE) release due to beta-2
blockade, we also measured NE levels at baseline and
peak exercise.
Methods
Thirty-three subjects treated chronically with carvedilol
(34.5 +3.4 mg; n=23) or metoprolol XL (77.5+17.3 mg;
n=10) referred for cardiopulmonary exercise testing were
studied prospectively. All subjects were in normal sinus
rhythm, achieved RER > 0.95, and received the long
acting form of metoprolol, metoprolol XL, which has
75% bioavailability of the short acting metoprolol IR.
Carvedilol versus metoprolol XL subjects did not differ

(p < 0.05) with respect to age (52 vs 56 yrs), LVEF (25
vs 29 %), LVEDD (6.2 vs 6.3 mm), MAP (83.5 vs. 88.3
mmHg), baseline HR (73.6+2.4 vs 71.5+4.7 bpm), peak
Vo2 (16.7 vs 15.7 ml/kg/min), exercise time (9.3 vs 9.1
min), or baseline (3.49 vs 4.01 nmol/l) plasma norepinephrine (NE) levels. However, despite similar peak NE
levels (17.1+1.8 vs 18.6+4.9 nmol/l), heart rate at peak
exercise was higher in subjects receiving carvedilol (131.7
+ 4.6 bpm) compared to those receiving metoprolol
(112.6 + 6.0 bpm), p=0.029.
Conclusion
Similar NE release and more complete beta-1 blockade
as assessed by peak heart rate is observed in otherwise
well matched subjects with CHF treated with a mean
daily dose of 77.5 mg metoprolol XL as compared to
35.5 mg carvedilol. Assuming a 75% bioavailability of
metoprolol XL, 58 mg metoprolol IR should provide a
higher degree of beta-1 blockade than 35 mg carvedilol.
Presented at 2004 Heart Failure Society of America
– Eighth Annual Scientific Meeting
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Resident and Faculty Feedback: The Student’s Perspective
Daniel J. Rubin MD, PGY-2
Kyle E. Rarey PhD, University of Florida
Background
Feedback from faculty members and residents is a critical component
of undergraduate medical education. Little is known about how
students assess the adequacy of feedback from faculty and residents.
Purpose
To report medical students’ evaluations of clinical teacher feedback
and to determine if students assess feedback given by residents
differently than they assess feedback given by faculty.
Methods
Data were retrospectively collected from medical students’ responses
to end-of-clerkship questionnaire items that evaluated feedback from
residents and attending physicians. The mean ratings of faculty
feedback in four clerkships were compared with the mean ratings of
resident feedback within each academic year from 1998 to 2002.
Results
Overall, the 1198 student evaluations of clinical teacher feedback
were positive. Resident feedback was rated equal to or higher than
faculty feedback in every clerkship; 5 of the 16 comparisons (31%)
reached statistical significance.
Conclusions
Students believe feedback from residents is at least as valuable as
feedback from faculty. Higher resident feedback ratings may have
been due to a greater frequency of resident-student interactions as
well as a more peer-level relationship between students and residents.

Background
Feedback refers to information describing students’
performance in a given activity that is intended to guide
future performance in that activity.1 Medical students
who receive feedback have been shown to perform better
on objective outcome measures than students who do
not receive feedback.2,3 Accordingly, feedback is
recognized as an important part of medical education.1,4
Effective feedback is timely, expected, frequent, nonjudgmental, non-threatening, and specific (based on
direct observation of behaviors).1,4 Feedback that lacks
these characteristics may fail to communicate useful
information to the student. Because of the potential for
variability in feedback, it is important for medical schools
to monitor feedback given to students.
Typically, clinical faculty and residents are both
responsible for teaching medical students and giving them
feedback.5 Because attending physicians tend to have
more teaching experience than residents, they might be
expected to provide better feedback. However, on most
clinical rotations residents spend more time with students
and therefore have the opportunity to provide more
frequent, specific feedback.6 Little is known about
whether students value feedback from residents differently
than they value feedback from attending physicians.
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The purpose of this study is to report medical students’
evaluations of clinical teacher feedback and to determine
if students assess feedback given by residents differently
than that given by faculty. To our knowledge, this is the
first study that specifically compares student ratings of
feedback from residents with feedback from faculty.
Methods
The University of Florida College of Medicine
administers a questionnaire to third-year medical
students at the end of each clinical clerkship. All
questionnaires contained the same 2 items to assess
feedback: (1) “Attending physicians provided regular
feedback on student performance,” and (2) “Residents
provided regular feedback on student performance.”
Possible responses ranged from “poor” (1) to
“excellent” (5) on a 5-point Likert scale. This study
involved a retrospective analysis of student responses
to these two items.
Questionnaires from Internal Medicine, Neurology,
Pediatrics, and Surgery were included. Questionnaires
from clerkships that did not provide feedback data from
all 4 years relating to both the faculty and residents were
excluded. For each clerkship within each academic year,
mean student ratings of resident feedback were compared
with mean ratings of faculty feedback using a t-test.
Results
The study included 1,198 questionnaires completed
between 1998 to 2002 by 455 students over 4 academic
years, yielding an overall response rate of 74%. The
response rates for individual clerkships were: Internal
Medicine 74%, Neurology 83%, Pediatrics 70%, and
Surgery 67%.
Overall, students rated feedback from both residents and
faculty in the range of good to very good. Mean scores
ranged from 3.1 to 4.1 for faculty feedback and from 3.3
to 4.2 for resident feedback (3 = good, 4 = very good).
Students rated feedback from residents equal to or higher
than feedback from faculty in every clerkship each year.
Resident feedback was rated significantly higher than
faculty feedback in 5 of the 16 resident-faculty
comparisons (1998: Neurology faculty 3.5±0.9, residents
4.1±1; Pediatrics faculty 3.4±1.1, residents 3.9±1.1;
Surgery faculty 3.1±1.2, residents 3.5±1.2; 1999:
Neurology faculty 3.7±1.1, residents 4.2±0.9; 2000:
Surgery faculty 3.4±1.3, residents 3.8±1.1).

Discussion
In this study, student responses to end-of-clerkship
questionnaires were retrospectively analyzed to assess and
compare student perception of feedback given by
attending physicians and residents. On average, students
rated feedback from all clinical teachers (residents and
attending physicians) as good or better. Resident feedback
was rated equal to or better than faculty feedback. The
difference was statistically significant for 31% of the
faculty-resident comparisons.

Future studies could address these limitations to better
assess and compare resident and faculty feedback. A more
useful instrument to measure the effectiveness of
feedback would be a questionnaire that specifically
addresses the component parts of effective feedback.8
Another valuable approach might be to train students in
recognizing and receiving feedback. Such training has
been shown to improve students’ ratings of feedback
given.9 To address the issue of feedback recall, students
could be surveyed multiple times during a clerkship.

Several factors may have contributed to higher ratings of
resident feedback. One is amount of time spent with
trainees. A study of internal medicine clerkship students
found that the amount of time clinical teachers spent with
students was related to student ratings of overall teaching
effectiveness.7 Residents generally spend more time with
medical students because faculty-student interactions
tend to be limited. Therefore, time spent with students
may have contributed to higher resident ratings.

In conclusion, this study shows that while medical
students were satisfied generally with the level of feedback
from all clinical teachers, they considered feedback from
residents as good as or better than feedback from faculty.
Because residents play a critical role in undergraduate
medical education, it is valuable to assess feedback from
residents as well as faculty. Further research is needed to
more objectively determine the effectiveness of feedback
given by residents and faculty.

Another factor that may have contributed to higher
ratings of resident feedback is that students considered
feedback from residents more personally acceptable. As
previously stated, effective feedback is non-threatening.4
Generally, students and residents are closer in age and
experience than students and attending physicians.
Students and residents, therefore, have more of a peer
relationship. Most likely, students feel less threatened by
residents than by attending physicians.
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Background
Prescribing information of nesiritide mandates priming
of intravenous tubing with 25 mL of nesiritide prior to
connecting the intravenous (IV) line to the patient, since
the drug may partially absorb to the line. Thus, 10% of
a reconstituted vial is wasted, with a cost of $40-50 per
line used. No study has quantified the binding effect of
nesiritide to intravenous tubing, tested binding
properties of different materials, or analyzed binding
effect of central lines, where priming cannot occur.
Furthermore, prescribing information states that
nesiritide must not be administered through a central
heparin-coated catheter, since it may bind to heparin.
However, no study quantified this binding effect.
Methods
1.5 mg vials of nesiritide were reconstituted into 250 mL
0.9% NS bags. A 23.3mL bolus, followed by 7mL/h 2hour infusion (2ug/kg bolus, 0.01ug/kg/min infusion for
a 70kg pt) were run, in duplicate, through 5 separate
experimental tubing systems: 1) Standard PVC
peripheral IV tubing primed with a 25 mL of nesiritide;
2) Standard non-primed PVC peripheral IV tubing; 3)
Non-primed polyethylene peripheral IV tubing,
commonly used for NTG infusion; 4) Non-primed PVC
peripheral IV tubing, connected distally to a central IV
polyurethane catheter; 5) Non-primed PVC peripheral
IV tubing, connected distally to a heparin-coated
pulmonary artery PVC catheter. Nesiritide concentration
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was measured, in triplicate, in the initial bags and
samples collected from the five IV settings, using Biosite
BNP test (Beckman Coulter).
Results
More than 95% of nesiritide was recovered from all five
IV settings. Priming of PVC tubing with nesiritide
improved drug recovery by 2% during IV bolus and 2hour infusion compared to non-primed PVC tubing.
Polyethylene tubing improved drug recovery also by 2%
at 1- and 2-hour time points, suggesting that
polyethylene saturates faster than PVC. Connecting a
triple lumen or heparin-coated pulmonary artery catheter
distally to non-primed PVC tubing did not further
impact percentage of drug recovery.
Conclusions
Priming of peripheral IV tubing with 25mL of nesiritide
minimally improves drug release to patients since more
than 95% of drug is delivered even without priming.
Polyethylene IV tubing further minimize drug binding
and offers an even more reliable, yet inexpensive,
alternative to priming. Elimination of priming may result
in $40-50 saving per line used. Use of central lines or
heparin-coated pulmonary catheter does not result in
significant binding. Thus, changes in nesiritide
prescribing information are warranted.
Presented at 2004 Heart Failure Society of America
– Eighth Annual Scientific Meeting
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